Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions

Open access
Johns, Claire, Seav, Susan M., Dominick, Sally A., Gorman, Jessica R., Li, Hongying, Natarajan, Loki, Mao, Jun James, Irene Su, H. · 2016 · Breast Cancer Research and Treatment

Abstract

Patient-centered decision making about hot flash treatments often incorporates a balance of efficacy and side effects in addition to patient preference. This systematic review examines randomized controlled trials (RCTs) comparing at least two non-hormonal hot flash treatments in breast cancer survivors. In July 2015, PubMed, SCOPUS, CINAHL, Cochrane, and Web of Science databases were searched for RCTs comparing active, non-hormonal hot flash treatments in female breast cancer survivors. Thirteen trials were included after identifying 906 potential studies. Four trials were dose comparison studies of pharmacologic treatments citalopram, venlafaxine, gabapentin, and paroxetine. Hot flash reduction did not differ by tamoxifen or aromatase inhibitor use. Citalopram 10, 20, and 30 mg daily had comparable outcomes. Venlafaxine 75 mg daily improved hot flashes without additional side effects from higher dosing. Gabapentin 900 mg daily improved hot flashes more than 300 mg. Paroxetine 10 mg daily had fewer side effects than 20 mg. Among four trials comparing different pharmacologic treatments, venlafaxine alleviated hot flash symptoms faster than clonidine; participants preferred venlafaxine over gabapentin. Five trials compared pharmacologic to non-pharmacologic treatments. Acupuncture had similar efficacy to venlafaxine and gabapentin but may have longer durability after completing treatment and fewer side effects. We could not perform a pooled meta-analysis because outcomes were not reported in comparable formats. Clinical trial data on non-hormonal hot flash treatments provide comparisons of hot flash efficacy and other patient important outcomes to guide clinical management. Clinicians can use the information to help patients select hot flash interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10549-016-3765-4

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Research works printed but not linked: 2

  1. Stewart AL, Ware JE (1992) Measuring Function and Well Being: The Medical Outcomes Study Approach. Duke University Press, Durham
  2. Meijman TF, de Vries-Griever AH, de Vries G (1988) The evaluation of the Groningen sleep quality scale. Heymans Bulletin (HB 88-13-EX), Groningen

Cited by

See all 72

Metadata

Authors
Johns, C., Seav, S. M., Dominick, S. A., Gorman, J. R., Li, H., Natarajan, L., Mao, J. J., & Irene Su, H.
Affiliations
  • University of California, San Francisco (US)
  • University of California San Diego (US)
  • Oregon State University (US)
  • Memorial Sloan Kettering Cancer Center (US)
Venue
Breast Cancer Research and Treatment
Published
2016-03-26
Volume
156
Issue
3
Pages
415-426
ISSN
  • 0167-6806 (ISSN-L)
  • 1573-7217
OpenAlex
W2310666724
Cited by
72
References
63
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 9 · 2021: 8 · 2020: 9 · 2019: 12 · 2018: 10 · 2017: 7 · 2016: 7
FWCI
1.77
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Breast Cancer Research and Treatment (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
California Breast Cancer Research Program (200B-0 144)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
Keywords
hot flashes, breast cancer survivors, venlafaxine, gabapentin, paroxetine, citalopram, clonidine, acupuncture, aromatase inhibitors, tamoxifen, patient-centered decision-making, dose comparison, adverse effects
MeSH terms
Serotonin and Noradrenaline Reuptake Inhibitors, Breast Neoplasms, Female, Humans, Randomized Controlled Trials as Topic, Treatment Outcome, Survivors, Evidence-Based Medicine, Disease Management, Hot Flashes, Patient Preference

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. https://app.cochat.ai/papers/10.1007/s10549-016-3765-4
The paper
Johns, C., Seav, S. M., Dominick, S. A., Gorman, J. R., Li, H., Natarajan, L., Mao, J. J., & Irene Su, H. (2016). Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-016-3765-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.